REQUEST A DEMO
Total
USD $0.00
Search more companies

Fosun Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Fosun Pharma Sp. z o.o. Profile Updated: September 09, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Fosun Pharma Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. Fosun Pharma Sp. z o.o. was incorporated on January 07, 2019. From the latest financial highlights, Fosun Pharma Sp. z o.o. reported a net sales revenue drop of 34.06% in 2022. There was a total growth of 28.49% in Fosun Pharma Sp. z o.o.’s total assets over the same period. The net profit margin of Fosun Pharma Sp. z o.o. decreased by 253.97% in 2022.

Headquarters
Ul. Zajecza 15
Warsaw; Mazowieckie; Postal Code: 00-351

Contact Details: Purchase the Fosun Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Fosun Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Fosun Pharma Sp. z o.o. report to view the information.
Incorporation Date:
January 07, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Fosun Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-34.06%
Total operating revenue
-34.06%
Operating profit (EBIT)
14.53%
EBITDA
14.49%
Net Profit (Loss) for the Period
8.18%
Total assets
28.49%
Total equity
-29.27%
Operating Profit Margin (ROS)
-171.36%
Net Profit Margin
-253.97%
Return on Equity (ROE)
-9.24%
Quick Ratio
10.04%
Cash Ratio
7.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?